Sort
48,018 grants matching “immunotherapy”
REGULATION OF ANTI-TUMOR IMMUNITY
$1,219,441Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2010 · CA
Pediatric Clinical Trials Program for AIDS
$1,219,019Baylor College Of Medicine · U01 · FY2002 · AI
TARGETING RETINOIC ACID SIGNALING FOR IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA
$1,218,749Trustees Of The University Of Pennsylvania, The · · FY2021 · Department of the Army
Innate inflammatory responses during pulmonary infections
$1,218,475Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
$1,218,233David Morris Colcher · Beckman Research Institute/City Of Hope · P01 · FY2012 · CA
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis
$1,217,659Peter A Calabresi · Johns Hopkins University · U01 · FY2024 · NS
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$1,216,570James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2011 · DK
Modulation of Biodefense Responses to Bacterial Pathogen
$1,215,884Leo Lefrancois · University Of Connecticut Sch Of Med/Dnt · P01 · FY2007 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,215,514Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
TRANSCRIPTIONAL MODULATION OF TUMOR-ASSOCIATED MACROPHAGES TO FACILITATE PROSTATE CANCER IMMUNOTHERAPY
$1,214,432The Johns Hopkins University · · FY2016 · Department of the Army
Clinical Trials of Patients with AIDS-Related Malignancies
$1,214,327Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
PEDIATRIC AIDS CLINICAL TRIALS PROGRAM
$1,212,235Baylor College Of Medicine · U01 · FY2001 · AI
PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION
$1,212,062Dana-Farber Cancer Institute · P01 · FY2003 · AI
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,211,771Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,211,771Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,211,368Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2021 · AI
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
$1,211,213Svetomir Nenad Markovic · Mayo Clinic Rochester · R01 · FY2025 · CA
Pulmonary innate immune activation for bioterror defense
$1,210,843Coley Pharmaceutical Group, Inc. · U01 · FY2003 · AI
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
$1,210,843Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2019 · AI
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform
$1,209,827Nathan Yee · Tambo, Inc. · R44 · FY2025 · TR
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,209,712Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2019 · AI
Novel Molecular Therapies of Prostate Cancer
$1,208,002Dario C. Altieri · Wistar Institute · P01 · FY2020 · CA
SBIR Phase II: High throughput and antigen specific T-cell receptor discovery for solid tumor treatments
$1,207,999Binbin Chen · Vcreate, Inc. · · FY2024 · TIP
Understanding thymic epithelial and hematopoietic stem cell-intrinsic immune abnormalities driving T1D in optimized HIS mouse models
$1,207,770Megan Sykes · Columbia University Health Sciences · UG3 · FY2025 · DK
Bastyr/UW Oncomycology Translational Research Center
$1,207,565Leanna J Standish · Bastyr University · U19 · FY2012 · AT